BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 7595748)

  • 1. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study.
    Bertelli G; Gozza A; Forno GB; Vidili MG; Silvestro S; Venturini M; Del Mastro L; Garrone O; Rosso R; Dini D
    J Clin Oncol; 1995 Nov; 13(11):2851-5. PubMed ID: 7595748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and management of extravasation of cytotoxic drugs.
    Bertelli G
    Drug Saf; 1995 Apr; 12(4):245-55. PubMed ID: 7646823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation.
    Olver IN; Aisner J; Hament A; Buchanan L; Bishop JF; Kaplan RS
    J Clin Oncol; 1988 Nov; 6(11):1732-5. PubMed ID: 3183703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: topical DMSO for mitomycin-C-induced skin ulceration.
    Alberts DS; Dorr RT
    Oncol Nurs Forum; 1991; 18(4):693-5. PubMed ID: 1906166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of extravasation of both doxorubicin and vincristine administration in a Y-site infusion.
    Comas D; Mateu J
    Ann Pharmacother; 1996 Mar; 30(3):244-6. PubMed ID: 8833558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and alpha-tocopherole.
    Ludwig CU; Stoll HR; Obrist R; Obrecht JP
    Eur J Cancer Clin Oncol; 1987 Mar; 23(3):327-9. PubMed ID: 3595692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The significance of extravasation in oncological care].
    Zatkóné Puskás G
    Magy Onkol; 2008 Mar; 52(1):75-80. PubMed ID: 18403301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation.
    Lawrence HJ; Walsh D; Zapotowski KA; Denham A; Goodnight SH; Gandara DR
    Cancer Chemother Pharmacol; 1989; 23(5):316-8. PubMed ID: 2706738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European Oncology Nursing Society extravasation guidelines.
    Wengström Y; Margulies A;
    Eur J Oncol Nurs; 2008 Sep; 12(4):357-61. PubMed ID: 18765210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity to topical dimethyl sulfoxide (DMSO) when used as an extravasation antidote.
    Creus N; Mateu J; Massó J; Codina C; Ribas J
    Pharm World Sci; 2002 Oct; 24(5):175-6. PubMed ID: 12426960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extravasation of chemotherapeutic agents: prevention and therapy].
    Jordan K; Grothe W; Schmoll HJ
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):33-7. PubMed ID: 15619172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of accidental extravasation of antitumor agents with dimethylsulfoxide and alpha-tocopherol].
    Bonnetblanc JM; Bordessoule D; Fayol J; Amici JM
    Ann Dermatol Venereol; 1996; 123(10):640-3. PubMed ID: 9615123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semisolid formulations containing dimethyl sulfoxide and alpha-tocopherol for the treatment of extravasation of antiblastic agents.
    Casiraghi A; Ardovino P; Minghetti P; Botta C; Gattini A; Montanari L
    Arch Dermatol Res; 2007 Jul; 299(4):201-7. PubMed ID: 17370081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidotes to vesicant chemotherapy extravasations.
    Dorr RT
    Blood Rev; 1990 Mar; 4(1):41-60. PubMed ID: 2182147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexrazoxane: new indication. Anthracycline extravasation: continue using dimethyl sulfoxide.
    Prescrire Int; 2009 Feb; 18(99):6-8. PubMed ID: 19382398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone.
    Langer SW; Thougaard AV; Sehested M; Jensen PB
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):125-8. PubMed ID: 16001176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity to topical dimethyl sulfoxide in a pediatric patient with anthracycline extravasation.
    Llinares ME; Bermúdez M; Fuster JL; Diaz MS; Gonzalez CM
    Pediatr Hematol Oncol; 2005; 22(1):49-52. PubMed ID: 15770831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine or dimethyl sulfoxide, or both, for the treatment of anthracycline extravasation in rats.
    Uzunoglu S; Cosar R; Cicin I; Ibis K; Demiralay E; Benlier E; Erdogan B; Kandulu H; Ozen A; Altaner S
    J Plast Surg Hand Surg; 2013 Oct; 47(5):339-43. PubMed ID: 23710793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection by alpha-tocopherol and dimethylsulfoxide (DMSO) against adriamycin induced skin ulcers in the rat.
    Svingen BA; Powis G; Appel PL; Scott M
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):189-92. PubMed ID: 7291726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimethyl sulfoxide therapy in the treatment of vesicant extravasation: two case presentations.
    St Germain B; Houlihan N; D'Amato S
    J Intraven Nurs; 1994; 17(5):261-6. PubMed ID: 7965372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.